hydrogen sulfide has been researched along with Idiopathic Parkinson Disease in 24 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Studies have shown that hydrogen sulfide (H2S) exerts a neuroprotective effect and may have a therapeutic value for treating neurodegenerative diseases including Parkinson's disease." | 3.88 | Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease. ( Babayan-Tazehkand, A; Haghdoost-Yazdi, H; Rastgoo, N; Sarbazi-Golezari, A; Sarookhani, MR, 2018) |
| "Hydrogen sulfide (H2S) has a neuroprotective effect during the neural injury of Parkinson's disease." | 1.43 | Involvement of microRNA-135a-5p in the Protective Effects of Hydrogen Sulfide Against Parkinson's Disease. ( Li, J; Liao, S; Lin, Y; Liu, Y; Quan, H; Yang, Q, 2016) |
| "Hydrogen sulfide (H2S) is a multifunctional signaling molecule that exerts neuroprotective effects in oxidative stress." | 1.39 | A ratiometric two-photon fluorescent probe reveals reduction in mitochondrial H2S production in Parkinson's disease gene knockout astrocytes. ( Bae, SK; Cho, BR; Choi, DJ; Heo, CH; Joe, EH; Kim, HM; Sen, D, 2013) |
| "Hydrogen sulfide (H(2)S) has been shown to protect neurons." | 1.37 | Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. ( Ichinose, F; Kakinohana, M; Kaneki, M; Kida, K; Marutani, E; Tokuda, K; Yamada, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (66.67) | 24.3611 |
| 2020's | 8 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, Q | 1 |
| Tang, HL | 1 |
| Tang, YY | 1 |
| Zhang, P | 1 |
| Kang, X | 1 |
| Zou, W | 1 |
| Tang, XQ | 2 |
| Murros, KE | 1 |
| Nagashima, F | 2 |
| Miyazaki, Y | 2 |
| Kanemaru, E | 2 |
| Ezaka, M | 2 |
| Hara, H | 2 |
| Sugiura, K | 2 |
| Boerboom, SL | 2 |
| Ostrom, KF | 2 |
| Jiang, W | 2 |
| Bloch, DB | 2 |
| Ichinose, F | 4 |
| Marutani, E | 3 |
| Nie, S | 1 |
| Jing, Z | 1 |
| Wang, J | 2 |
| Deng, Y | 1 |
| Zhang, Y | 1 |
| Ye, Z | 1 |
| Ge, Y | 1 |
| Wu, K | 1 |
| Wang, X | 2 |
| Gong, L | 1 |
| Zhai, X | 1 |
| Wang, K | 1 |
| Qiu, X | 1 |
| Zhang, H | 1 |
| Tang, Z | 1 |
| Jiang, H | 1 |
| Shen, Q | 1 |
| Huang, Z | 1 |
| Zhang, D | 1 |
| Chen, X | 1 |
| Du, F | 1 |
| Zhou, Z | 1 |
| Fu, C | 1 |
| Li, L | 1 |
| Yang, N | 1 |
| Yu, C | 1 |
| Liu, L | 1 |
| Wang, H | 1 |
| Shen, W | 1 |
| Wang, P | 1 |
| Xie, Z | 1 |
| Zhou, H | 1 |
| Hu, Y | 1 |
| Fu, M | 1 |
| Zhu, Q | 1 |
| Shefa, U | 1 |
| Yeo, SG | 1 |
| Kim, MS | 1 |
| Song, IO | 1 |
| Jung, J | 1 |
| Jeong, NY | 1 |
| Huh, Y | 1 |
| Cakmak, YO | 2 |
| Cao, X | 1 |
| Cao, L | 1 |
| Ding, L | 1 |
| Bian, JS | 2 |
| Yuan, YQ | 1 |
| Wang, YL | 1 |
| Yuan, BS | 1 |
| Yuan, X | 1 |
| Hou, XO | 1 |
| Liu, CF | 2 |
| Hu, LF | 1 |
| Barbe, AG | 1 |
| Deutscher, DHC | 1 |
| Derman, SHM | 1 |
| Hellmich, M | 1 |
| Noack, MJ | 1 |
| Sarookhani, MR | 1 |
| Haghdoost-Yazdi, H | 2 |
| Sarbazi-Golezari, A | 1 |
| Babayan-Tazehkand, A | 2 |
| Rastgoo, N | 2 |
| Sarukhani, M | 1 |
| Sarbazi Golezari, A | 1 |
| Dargahi, T | 1 |
| Bae, SK | 1 |
| Heo, CH | 1 |
| Choi, DJ | 1 |
| Sen, D | 1 |
| Joe, EH | 1 |
| Cho, BR | 1 |
| Kim, HM | 1 |
| Paul, BD | 1 |
| Snyder, SH | 1 |
| Kida, K | 2 |
| Liu, Y | 1 |
| Liao, S | 1 |
| Quan, H | 1 |
| Lin, Y | 1 |
| Li, J | 1 |
| Yang, Q | 1 |
| Fan, LL | 1 |
| Li, YJ | 2 |
| Shen, XT | 1 |
| Zhuan, YY | 1 |
| He, JQ | 1 |
| Xu, JH | 1 |
| Hu, B | 1 |
| Lee, M | 1 |
| Tazzari, V | 1 |
| Giustarini, D | 1 |
| Rossi, R | 1 |
| Sparatore, A | 1 |
| Del Soldato, P | 1 |
| McGeer, E | 1 |
| McGeer, PL | 1 |
| Yamada, M | 1 |
| Tokuda, K | 1 |
| Kakinohana, M | 1 |
| Kaneki, M | 1 |
| Du, CC | 1 |
| Xu, JM | 1 |
6 reviews available for hydrogen sulfide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson's Disease.
Topics: alpha-Synuclein; Bacteria; Humans; Hydrogen Sulfide; Iron; Parkinson Disease | 2022 |
Role of Gasotransmitters in Oxidative Stresses, Neuroinflammation, and Neuronal Repair.
Topics: Alzheimer Disease; Carbon Monoxide; Cardiovascular System; Gasotransmitters; Humans; Hydrogen Sulfid | 2017 |
Rotorua, hydrogen sulphide and Parkinson's disease-A possible beneficial link?
Topics: Air Pollutants; Animals; Humans; Hydrogen Sulfide; Models, Animal; New Zealand; Parkinson Disease | 2017 |
A New Hope for a Devastating Disease: Hydrogen Sulfide in Parkinson's Disease.
Topics: Animals; Apoptosis; Brain; Disease Models, Animal; Humans; Hydrogen Sulfide; Neurons; Parkinson Dise | 2018 |
Modes of physiologic H2S signaling in the brain and peripheral tissues.
Topics: Animals; Brain; Cardiovascular System; Gasotransmitters; Gastrointestinal Tract; Homeostasis; Humans | 2015 |
Hydrogen Sulfide and Neuroinflammation.
Topics: Animals; Apoptosis; Humans; Hydrogen Sulfide; Inflammation; Parkinson Disease | 2015 |
18 other studies available for hydrogen sulfide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Hydrogen Sulfide Attenuates the Cognitive Dysfunction in Parkinson's Disease Rats via Promoting Hippocampal Microglia M2 Polarization by Enhancement of Hippocampal Warburg Effect.
Topics: Animals; Cognitive Dysfunction; Hippocampus; Humans; Hydrogen Sulfide; Male; Microglia; Parkinson Di | 2022 |
Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Hydrogen Sulfide; Mice; Parkinson Disease; Quinones; Sulfides | 2023 |
Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Hydrogen Sulfide; Mice; Parkinson Disease; Quinones; Sulfides | 2023 |
Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Hydrogen Sulfide; Mice; Parkinson Disease; Quinones; Sulfides | 2023 |
Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Hydrogen Sulfide; Mice; Parkinson Disease; Quinones; Sulfides | 2023 |
The link between increased Desulfovibrio and disease severity in Parkinson's disease.
Topics: Desulfovibrio; Humans; Hydrogen Sulfide; Neurodegenerative Diseases; Parkinson Disease; Patient Acui | 2023 |
Screening of H
Topics: Biosensing Techniques; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Mitochondria; Neurode | 2023 |
A novel coumarin-fluorescein-based fluorescent probe for ultrafast and visual detection of H
Topics: Animals; Coumarins; Fluorescein; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Parkinson D | 2024 |
Hydrogen sulfide alleviates oxidative stress injury and reduces apoptosis induced by MPP
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Caspase 3; Cell Survival; Gasotransmitters; Herbicides; Huma | 2020 |
A bifunctional probe reveals increased viscosity and hydrogen sulfide in zebra fish model of Parkinson's disease.
Topics: Animals; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Parkinson Disease; Viscosity; Zebra | 2021 |
Impaired CBS-H
Topics: Animals; Astrocytes; Cell Line, Tumor; Cells, Cultured; Corpus Striatum; Cystathionine beta-Synthase | 2018 |
Subjective and objective halitosis among patients with Parkinson's disease.
Topics: Aged; Case-Control Studies; Female; Halitosis; Humans; Hydrogen Sulfide; Male; Parkinson Disease; Sa | 2017 |
Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
Topics: Adenosine Triphosphate; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine; Dop | 2018 |
Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Topics: Analysis of Variance; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopam | 2018 |
A ratiometric two-photon fluorescent probe reveals reduction in mitochondrial H2S production in Parkinson's disease gene knockout astrocytes.
Topics: Astrocytes; Fluorescent Dyes; Humans; Hydrogen Sulfide; Intracellular Signaling Peptides and Protein | 2013 |
Coffee consumption, smoking, and Parkinson's disease? The beneficial role of hydrogen sulfide.
Topics: Coffee; Humans; Hydrogen Sulfide; Parkinson Disease; Risk Factors; Smoking | 2016 |
Involvement of microRNA-135a-5p in the Protective Effects of Hydrogen Sulfide Against Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3' Untranslated Regions; Animals; Apomorphine; Astrocy | 2016 |
Inhibition of hydrogen sulfide generation contributes to 1-methy-4-phenylpyridinium ion-induced neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Survival; Humans; Hydrogen Sulfide; Neurons; Parkinson Di | 2011 |
Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.
Topics: Animals; Cell Line; Cell Line, Tumor; Humans; Hydrogen Sulfide; Interleukin-6; Levodopa; Mitochondri | 2010 |
Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Inhalation; Animals; Apoptosis; Base S | 2011 |
[Hydrogen sulfide: a promising target for the treatment of Parkinson's disease].
Topics: Animals; Humans; Hydrogen Sulfide; Parkinson Disease | 2012 |